Pier Capital, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 168 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
Pier Capital, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,653,213
-41.9%
262,832
-0.3%
0.27%
-44.6%
Q3 2022$2,847,000
-66.3%
263,580
-64.4%
0.49%
-66.0%
Q2 2022$8,442,000
+24.1%
740,556
-0.8%
1.44%
+65.9%
Q1 2022$6,802,000
+54.6%
746,669
+153.1%
0.87%
+87.1%
Q4 2021$4,401,000
-62.0%
294,968
-34.5%
0.46%
-61.3%
Q3 2021$11,570,000
+59.1%
450,182
+61.5%
1.20%
+64.5%
Q2 2021$7,272,000
-24.7%
278,828
+1.9%
0.73%
-20.4%
Q1 2021$9,660,000
+151.7%
273,646
+79.9%
0.92%
+125.6%
Q4 2020$3,838,000
-31.3%
152,071
+2.6%
0.41%
-50.2%
Q3 2020$5,590,000148,2280.82%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders